under double blind conditions. This was to be done in a phased way so that there were three matched groups. In the first group, within days of starting placebo all four broke down with acute manic illnesses requiring admission to hospital. Because of this, the code hadto be broken and the trial halted, as it was felt to be Un ethical to risk any further episodes ofmania occurring, even in the cause of clarifying the questions raised by the study. This study is therefore a double blind controlled trial of lithium withdrawal in a small group, and attempts to examine the particular features ofthose who relapsed.
The Study
Seven male and eight female patients enrolled in the study. The average age was 49 years (range 20 to 60): the average age of onset of illness was 31 years, with an average frequency of 0.8 illnesses per year preceding (Hamilton, 1969) , life events score (Holmes and Rahe, 1967) , Global Assessment scores (Endicott et a!, 1976 ) and mania scale (Young et a!, 1978) . See Table I .
There were no significant differences between the placebo group and the active drug group on any of these measures ; thus the placebo group seems to us to have been typical ofthe group as a whole.
Results
All four placebo patients but none of the I 1 continuing active treatment group relapsed. This is a highly significant difference (Fisher Exact Test P = .0095). Details of all four patients, (who had been perfectly well at the start of the study) are shown in Table I and Fig 1. All suffered full-blown manic illnesses whilst on placebo. Of these, two had to be admitted on Section 25 of the Mental Health Act. One male was very disturbed and spent a large sum of money on purchasing a car which he could ill afford. He was subsequently ejected from the marital home by his wife and disappeared for 48 hours. A female patient, who had been well for two years, was beaten up by her husband who could not cope with'her over activity and incessant demands. A second female showed marked flight of ideas with pressure of speech, sleeplessness and grandiose delusional ideas. She became obsessed with erotic fantasies which were completely out of keeping with her previous person ality. The third female patient was ofspecial interest as she had never had a manic illness of serious clinical proportions before. She was diagnosed as cyclo thymic and had been liable to recurrent marked surges of loss of hope and pessimism on the one hand and unwarranted cheerfulness on the other. These were generally thought not to be of sufficient severity and duration to meet the criteria for a major de pressive or manic episode, but had been very dis Fyro and Petterson (1977) . They differ in several ways, e.g. design, duration of trial, criteria for selection (Schou and Thomsen, 1975) . The studies indicate that longterm lithium administration prevents or attenu ates a recurrence of affective illness, and do not suggest a rebound syndrome. The evidence favours gradual relapse spread over a period of months. Fyro and Petterson (1977) report that at the termination of their investigation, three of nine patients in receipt of lithium discontinued their medication and relapsed into mania. Although this was adduced as further evidence in support ofthe prophylacticeffect of lithium in manic depressive disease, the acuteness of time relationships were not discussed any further.
it is not clear what factors are operating to cause the acute breakdowns suffered by our patients. They are a highly selected group by virtue of being in a lithium clinic and taking no other medication. Three had a previous liability to severe bipolar illness necessitating hospital treatment. All were functioning at a high level socially and professionally (Table I ) and could therefore be regarded as deriving considerable benefit from lithium treatment. However, it is of some interest to note that we have been unable to demonstrate any conclusive proof of positive family history of manic depression in any of these patients. Such a history might be expected in a group sensitive to lithium.
The observation made here may have an important clinical implication. Thus, there may be a small mm ority of non-compliant rapidly relapsing patients who take their lithium only when under supervision of hospital staff or their relatives. When supervision is relaxed, these patients stop their lithium and such intermittent use could perhaps result in rebound ill nesses additional to the illness they might otherwise have suffered. Even if rebound illnesses are un common, gradual withdrawal of lithium may be less provocative than abrupt cessation. AcraPsychiatrica Scandinavica, 65, 310â€"14. E@icorr, J., SPITZER, R., Fiiiss, J. & COHEN, J. (1976) The global assessment scale. A procedure for meas uring overall severity of psychiatric disturbance. Archives ofGeneralPsychiatry, 33, 766â€"77.
